Using design thinking to differentiate useful from misleading evidence in observational research

JAMA - Journal of the American Medical Association

Volumn 317, Issue 7, 2017, Pages 705-707

  Goodman, Steven N ^a   Schneeweiss, Sebastian ^b   Baiocchi, Michael ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; MODEL; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; QUALITY CONTROL; STUDY DESIGN; METHODOLOGY; RESEARCH; THINKING;

RESEARCH; RESEARCH DESIGN; THINKING;

EID: 85014639703     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.19970     Document Type: Editorial

References (21)

1. Kesselheim AS, Avorn J. New "21st Century Cures" legislation: speed and ease vs science [published online January 5, 2017]. JAMA. doi:10.1001/jama.2016.20640
2. Agoritsas T, Merglen A, Shah ND, O'Donnell M, Guyatt GH. Adjusted analyses in studies addressing therapy and harm: Users' Guides to the Medical Literature. JAMA. doi:10.1001/jama.2016.20029
3. Hernán MA, Taubman SL. Does obesity shorten life? the importance of well-defined interventions to answer causal questions. Int J Obes (Lond). 2008;32(suppl 3):S8-S14.
4. Petersen ML, van der Laan MJ. Causal models and learning from data: integrating causal modeling and statistical estimation. Epidemiology. 2014;25 (3):418-426.
5. Rubin DB. For objective causal inference, design trumps analysis. Ann Appl Stat. 2008;2(3):808-840.
6. Hernán MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19(6):766-779.
7. Moride Y, Abenhaim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research [published correction appears in J Clin Epidemiol. 2004;57(1):111]. J Clin Epidemiol. 1994;47(7):731-737.
8. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008;358(8):771-783.
9. Graham DJ, Reichman ME, Wernecke M, et al. Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation. JAMA Intern Med. 2016;176(11):1662-1671.
10. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006;17(3): 268-275.
11. Setoguchi S, Warner Stevenson L, Stewart GC, et al. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure. BMJ. 2014;348:g2866.
12. Vandenbroucke JP, Psaty BM. Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects. JAMA. 2008;300(20):2417-2419.
13. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167 (4):492-499.
14. Gruber S, Chakravarty A, Heckbert SR, et al. Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association. Pharmacoepidemiol Drug Saf. 2016;25(9):973-981.
15. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20 (4):488-495.
16. Simmons JP, Nelson LD, Simonsohn U. False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci. 2011;22(11): 1359-1366.
17. Leamer EE. Specification Searches: Ad Hoc Inference With Nonexperimental Data. Hoboken, NJ: John Wiley & Sons; 1978.
18. Taylor J, Tibshirani RJ. Statistical learning and selective inference. Proc Natl Acad Sci U S A. 2015; 112(25):7629-7634.
19. Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC, Greenland S. Good practices for quantitative bias analysis. Int J Epidemiol. 2014;43 (6):1969-1985.
20. Ding P, Van der Weele TJ. Sensitivity analysis without assumptions. Epidemiology. 2016;27(3): 368-377.
21. Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence-what is it and what can it tell us? N Engl J Med. 2016;375(23):2293-2297.